Original Articles

You have full text access to this OnlineOpen article

Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors†

  1. Richard S. Mangus‡,*,
  2. Jonathon A. Fridell,
  3. Rodrigo M. Vianna,
  4. Martin A. Milgrom,
  5. Paul Chestovich,
  6. Ray K. Chihara,
  7. A. Joseph Tector

Article first published online: 27 FEB 2008

DOI: 10.1002/lt.21372

Issue

Liver Transplantation

Liver Transplantation

Volume 14, Issue 3, pages 365–373, March 2008

Additional Information

How to Cite

Mangus, R. S., Fridell, J. A., Vianna, R. M., Milgrom, M. A., Chestovich, P., Chihara, R. K. and Tector, A. J. (2008), Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl, 14: 365–373. doi: 10.1002/lt.21372

Author Information

  1. Department of Surgery, Transplantation Section, Indiana University School of Medicine, Indianapolis, IN

  1. ‡

    Telephone: 317-274-4370; FAX: 317-278-3268

*Transplant Division, Department of Surgery, Indiana University School of Medicine, 550 North University Boulevard, Room 4258, Indianapolis, IN 46202-5250

  1. †

    This article was presented at the World Transplant Congress, Boston, MA, 2006.

Publication History

  1. Issue published online: 27 FEB 2008
  2. Article first published online: 27 FEB 2008
  3. Manuscript Accepted: 19 SEP 2007
  4. Manuscript Received: 11 JUN 2007

Funded by

  • Health Outcomes Research Feasibility Fund of the General Clinical Research Center at the Indiana University School of Medicine

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (420K)

REFERENCES

  • 1
    Englesbe MJ, Heidt D, Sung R, Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? Transplantation 2006; 81: 1750–1752.
  • 2
    Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006; 81: 480–482.
  • 3
    Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005; 37: 2016–2019.
  • 4
    de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999; 12: 447–453.
  • 5
    Fridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77: 1304–1306.
  • 6
    Agarwal A, Murdock P, Pescovitz MD, Goggins WC, Milgrom ML, Fridell JA. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant Proc 2005; 37: 3523–3526.
  • 7
    Potdar S, Malek S, Eghtesad B, Shapiro R, Basu A, Patel K, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18: 661–665.
    Direct Link:
  • 8
    Englesbe MJ, Moyer A, Kim DY, Granger DK, Pietroski R, Yoshida A, et al. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006; 82: 136–139.
  • 9
    Mangus RS, Tector AJ, Agarwal A, Vianna R, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006; 12: 226–230.
    Direct Link:
  • 10
    Erhard J, Lange R, Scherer R, Kox WJ, Bretschneider HJ, Gebhard MM, et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994; 7: 177–181.
  • 11
    Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28: 295–302.
  • 12
    Hatano E, Kiuchi T, Tanaka A, Shinohara H, Kitai T, Satoh S, et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Lond) 1997; 93: 81–88.
  • 13
    Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003; 88: 145–151.
  • 14
    Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004; 10: 1415–1421.
    Direct Link:
  • 15
    Testa G, Malago M, Nadalin S, Treptow B, Paul A, Frilling A, et al. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl 2003; 9: 822–826.
    Direct Link:
  • 16
    Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439–450.
  • 17
    Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? Hepatology 2006; 45: 484–488.
  • 18
    Eghtesad B, Aucejo F, Fung JJ. Preservation solutions in liver transplantation: what are the options. Liver Transpl 2006; 12: 196–198.
    Direct Link:
View Full Article (HTML) Get PDF (420K)